Discover
VANI
Vivani Medical, Inc.
1.19
3 x 1.19
2 x 1.51
bid
ask
-
0.02
1.65%
3 @ 07:41 PM
1.20 +0.01 (0.84%)
| Ytd | -3.25% | |
| 1y | -19.05% |
1.17
day range
1.23
0.94
52 week range
1.87
| Open | 1.22 | Prev Close | 1.21 | Low | 1.17 | High | 1.23 | Mkt Cap | 107.34M |
| Vol | 904.58K | Avg Vol | 480.20K | EPS | -0.36 | P/E | N/A | Forward P/E | -2.11 |
| Beta | 3.52 | Short Ratio | 12.59 | Inst. Own | 10.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 1.36 | 200-d Avg | 1.28 | 1yr Est | 5.50 |
| Income Statement | |||
| Operating Expenses | 6.87M | ||
| Research and Development Expense | 4.46M | ||
| Selling, General and Administrative Expense | 2.42M | ||
| Operating Income | -6.87M | ||
| Net Income | -6.37M | ||
| Net Income Common Stock | -6.37M | ||
| Net Income Common Stock (USD) | -6.37M | ||
| Consolidated Income | -6.37M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -6.37M | ||
| Earning Before Interest & Taxes (USD) | -6.37M | ||
| Weighted Average Shares | 87.09M | ||
| Weighted Average Shares Diluted | 87.09M | ||
| Balance Sheet | |||
| Cash and Equivalents | 20.79M | ||
| Cash and Equivalents (USD) | 20.79M | ||
| Current Assets | 21.64M | ||
| Property, Plant & Equipment Net | 19.02M | ||
| Total Assets | 41.64M | ||
| Total Debt | 16.01M | ||
| Current Liabilities | 6.66M | ||
| Debt Non-Current | 16.01M | ||
| Total Liabilities | 22.67M | ||
| Accumulated Retained Earnings (Deficit) | -161.68M | ||
| Accumulated Other Comprehensive Income | 32.00K | ||
| Shareholders Equity | 18.97M | ||
| Shareholders Equity (USD) | 18.97M | ||
| Assets Non-Current | 20.00M | ||
| Total Debt (USD) | 16.01M | ||
| Liabilities Non-Current | 16.01M | ||
| Trade and Non-Trade Payables | 1.20M | ||
| Tax Assets | 709.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 156.00K | ||
| Net Cash Flow from Financing | 5.83M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -301.00K | ||
| Capital Expenditure | -99.00K | ||
| Issuance (Purchase) of Equity Shares | 5.94M | ||
| Issuance (Repayment) of Debt Securities | -106.00K | ||
| Net Cash Flow from Investing | -99.00K | ||
| Net Cash Flow from Operations | -6.03M | ||
| Share Based Compensation | 313.00K | ||